Research progress of gefitinib combined with radiotherapy for patients with advanced non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2015.07.017
- VernacularTitle:吉非替尼联合放疗治疗晚期非小细胞肺癌的研究进展
- Author:
Aihua PENG
;
Youxiong SHI
;
Guosheng FENG
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Radiotherapy;
Gefitinib
- From:
Journal of International Oncology
2015;(7):539-541
- CountryChina
- Language:Chinese
-
Abstract:
Studies confirm that gefitinib treatment of epidermal growth factor receptor(EGFR)muta-tions for patients with non-small cell lung cancer(NSCLC)has a clear effect,and with radiotherapy sensitiza-tion effect. Many studies both at home and abroad show that gefitinib combined with radiotherapy can signifi-cantly improve the survival times of patients,especially for the elderly patients or the patients with brain metas-tases,which has fewer adverse reactions and with higher life qualities. Therefore,gefitinib combined with radiotherapy will be an effective treatment for the patients with advanced NSCLC.
